As a pioneer in the field of precision radiotherapy and stereotactic radiosurgery (SRS), we support doctors by developing innovative technology that enables the best possible treatment options for patients.
Radiotherapy: An essential building block for combination therapies
Although the number of cancer cases increases yearly, the rate of mortality from solid tumor cancers is slowly decreasing1. In the last years, radiosurgery has played an increasingly important role in combination with surgery, chemotherapies and immunotherapies for cancer treatment.
As one of the leaders in the field of precision radiotherapy and stereotactic radiosurgery, we are motivated to critically evaluate and address unmet technological needs as well as consistently question the status quo. Our goal is to make high-quality radiosurgery accessible to physicians and patients worldwide. Radiosurgery can be beneficial to patients because, through this approach, solid tumors can be treated non-invasively and with only a few fractions of radiation. By sparing the patient’s healthy tissue as much as possible and preserving cognitive functions, the patient’s quality of life remains fully in focus.
Focusing on precision to improve quality of life
By using Brainlab technology, physicians receive indication-specific tools for personalized decision-making and dose planning. Due to automated processes, treatment plans can be adapted to clinical needs within a very short timeframe. Brainlab software and hardware ensures accuracy from treatment planning to submillimetric precision during irradiation with the power of cutting-edge tracking technologies.
Based on our experience in cranial and spinal radiosurgery, Brainlab is developing indication-specific solutions for precise treatments of extracranial tumors such as in breast and lung.
Digitalization for individual, personalized therapies
In general, one-size-fits-all treatments no longer apply. All cancer patients require personalized therapy. Digitalization and the use of digital patient data will lead radiosurgery into a new era. In the future, our approach will increasingly shift towards gaining deeper insights from existing data.
This information will be fed back into the software and, using artificial intelligence, will be used to draw conclusions and make recommendations for treatments. On top of this, both genetic and clinical data will be taken into consideration during treatment planning.
Learn more about Brainlab radiosurgery products.
1 Cancer deaths rose to 10 million worldwide in 2019 | Institute for Health Metrics and Evaluation (healthdata.org)
